CClinicalTrials.gg
CompletedNCT06437405Updated Apr 9, 2025

Resistance Exercise Plus Vinegar Ingestion on Biomarkers in Healthy Adults

An interventional study of Vinegar liquid and vinegar pill in LPS, Mood Disorders and Cognitive Change, sponsored by Arizona State University. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-09.

Sponsored by Arizona State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Given its capacity to stimulate exercise-induced neuroplasticity at lower doses compared to aerobic exercise, resistance exercise has become the top-recommended rehabilitation approach for individuals with neurocognitive impairments. Despite a large body of evidence supporting its application in the context of cognition, little work has been done to investigate the role of resistance exercise in modifying the structure and function of the microbiota-gut-brain axis. Likewise, despite a general understanding of the benefits of short chain fatty acids such as acetate for the gut-brain axis, the impact of exogenous acetic acid has not been sufficiently examined in the context of the intestinal barrier. While self-reported mood disturbance responds favorably to vinegar ingestion, it is currently unknown if these effects are also associated with changes in intestinal permeability.

Read the detailed description

Existing resistance exercise interventions have produced promising outcomes indicating favorable shifts in microbial composition, intestinal barrier integrity, and serum biomarkers of inflammation. These changes appear to be particularly pronounced in individuals experiencing greater enhancements in lean mass, implying a crucial role for the hypertrophic effects of the exercise protocol. Given the current knowledge surrounding age-related cognitive decline and the pathophysiology of neurological and psychiatric disorders, it seems that many of the mechanisms significantly influenced by resistance exercise could contribute to reducing the risk or, at the very least, delaying the onset of these conditions. Considering the observed neuroplastic and neuroprotective effects of resistance exercise on the brain, it is plausible to hypothesize that the mitigation of excessive intestinal permeability and subsequent neuroinflammation may further support overall brain function. Given the potential for vinegar to enhance these outcomes, investigating the combined effects of exercise and vinegar ingestion may provide valuable insights into how lifestyle interventions can effectively promote cognitive and mental health. Therefore, the purpose of this work is to assess whether the combination of resistance exercise and vinegar ingestion elicits more favorable shifts in gut barrier function, cognition, and mental health compared to resistance exercise alone. This investigation aims to demonstrate the potential efficacy of this integrated approach in fostering long-team health outcomes.

02

Conditions studied

  • LPS
  • Mood Disorders
  • Cognitive Change

Browse trials for

Keywords

  • vinegar
  • resistance training
  • strength
  • depression
03

In context

Mood Disorders

584 studies on the registry are indexed under Mood Disorders; 117 are open to participants now.

This study's enrollment of 29 is below the median of 72 across 429 interventional studies indexed under Mood Disorders.

Browse Mood Disorders studies →

Lead sponsor

Arizona State University is the lead sponsor of 234 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. premenopausal (for those assigned female at birth)
  2. willing and able to participate in moderate to vigorous exercise as determined by the ACSM Health/Fitness Facility Preparticipation Screening Questionnaire
  3. sedentary (defined as a score \<14 on the Godin-Shepard Leisure Time Physical Activity Questionnaire (GSLTQ))
  4. equipped with access to a complete gym
  5. available for all lab visits (at weeks 0, 3, 9, and 15)

Exclusion criteria

Exclusion Criteria:

  1. antibiotic use within the past three months
  2. prebiotic, probiotic, or high-dose antioxidant supplementation within the past month
  3. regular engagement in moderate to vigorous exercise
  4. following a vegetarian diet
  5. presence of any medical/psychiatric disease
  6. presence of any gastrointestinal disorder such as irritable bowel syndrome, inflammatory bowel disease, Crohn's disease, diverticulitis/diverticulosis, etc.
  7. actively pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Liquid vinegar

    2 tablespoons of liquid apple cider vinegar (5% acidity) diluted in one cup of water twice daily with meals providing 1.5g acetic acid.

    Dietary Supplement: Vinegar liquid

  • Placebo comparator
    Vinegar pill

    one apple cider vinegar tablet (0.022g acetic acid) daily.

    Dietary Supplement: vinegar pill

Interventions

  • Dietary supplementVinegar liquid

    one pill daily

    Also known as: Vinegar pill

  • Dietary supplementvinegar pill

    One pill daily

06

What researchers measure

Primary outcomes

  1. Lipopolysaccharide

    measured indirectly via LPS binding protein

    Time frame: 12 weeks

  2. Depression

    measured via Profile of Mood States (POMS) questionnaire

    Time frame: 12 weeks

  3. Cognitive change

    measured using Trail Making Test

    Time frame: 12 weeks

07

Study locations

1 site
  • 850 PBC
    Phoenix, Arizona 85004, United States
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share data beyond study investigators.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06437405
Lead sponsor
Arizona State University
Responsible party
Carol Johnston (Professor and Associate Dean, Arizona State University) — Principal investigator
First posted
May 31, 2024
Start date
May 22, 2024
Primary completion
Feb 15, 2025
Completion
Feb 15, 2025
Last update
Apr 9, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion